PublicationsMomelotinib reduces cancer stem cell load leading to a decreased tumor burden and a prolonged disease-free remission period in a mouse model of human ovarian cancerPublicationsMomelotinib reduces cancer stem cell load leading to a decreased tumor burden and a prolonged disease-free remission period in a mouse model of human ovarian cancer